搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
drugdeliverybusiness
2 天
Senseonics reports mixed Q3 results, positive Eversense 365 outlook
Senseonics (NYSE:SENS) shares dipped slightly before hours today on third-quarter results that came in mixed compared to the consensus forecast. Shares of SENS fell 2.5% to 34¢ apiece in pre-market ...
drugdeliverybusiness
2 天
Insulet stock rises on Q3 beat, raised sales guidance
Insulet (Nasdaq:PODD) shares ticked up today on third-quarter results that came in well ahead of the consensus forecast.
drugdeliverybusiness
3 天
Tandem stock rises on 31% Q3 sales growth, raised guidance
Tandem Diabetes Care shares ticked up after hours today on third-quarter results that topped the consensus forecast.
drugdeliverybusiness
3 天
Insulin pump maker PharmaSens adds former ADA leaders, medtech veterans to board
PharmaSens announced today that it appointed Dr. Robert A. Gabbay and James L. Peterson to its board of directors.
drugdeliverybusiness
5 天
Abbott reports sustained benefits with Esprit drug-eluting stent
The Espirit everolimus-eluting scaffold. [Image from the Abbott website] Abbott (NYSE:ABT) today announced data demonstrating ...
drugdeliverybusiness
8 天
Medtronic kicks off Blue Balloon Challenge for National Diabetes Awareness Month
Que Dallara, EVP and president of Medtronic Diabetes, wrote on LinkedIn: ...
drugdeliverybusiness
9 天
Insulet announces diabetes awareness initiatives for November
Insulet (Nasdaq:PODD) today announced its plans to recognize National Diabetes Awareness Month and World Diabetes Day.
drugdeliverybusiness
10 天
FDA approves Abbott CGMs for use during medical imaging
Abbott announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures.
drugdeliverybusiness
11 天
Beta Bionics launches iLet bionic pancreas with Abbott FreeStyle Libre 3 Plus
Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈